Darusentan Effect on PET Uptake Heterogeneity
NCT00738049
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Endothelial Dysfunction
Interventions
DRUG:
darusentan 100 mg
Sponsor
K.Lance Gould
Collaborators
[object Object]